Tue, June 19, 2018
Mon, June 18, 2018
Fri, June 15, 2018
Thu, June 14, 2018
Wed, June 13, 2018
Tue, June 12, 2018
Mon, June 11, 2018
Fri, June 8, 2018
Thu, June 7, 2018
Wed, June 6, 2018
Tue, June 5, 2018
Mon, June 4, 2018
Fri, June 1, 2018
Thu, May 31, 2018
Wed, May 30, 2018
Tue, May 29, 2018
Fri, May 25, 2018
Thu, May 24, 2018
Wed, May 23, 2018
Tue, May 22, 2018
Mon, May 21, 2018
Fri, May 18, 2018

Konstantinos Aprilakis Maintained (BPMC) at Buy with Decreased Target to $103 on, Jun 4th, 2018


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-103-on-jun-4th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Konstantinos Aprilakis of JMP Securities, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Decreased Target from $109 to $103 on, Jun 4th, 2018.

Konstantinos has made no other calls on BPMC in the last 4 months.



There is 1 other peer that has a rating on BPMC. Out of the 1 peers that are also analyzing BPMC, 0 agree with Konstantinos's Rating of Hold.



This is the rating of the analyst that currently disagrees with Konstantinos


  • David Nierengarten of "Wedbush" Maintained at Buy with Increased Target to $106 on, Monday, April 16th, 2018

Publication Contributing Sources